2 weeks Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates Zacks

Aurinia (AUPH) delivered earnings and revenue surprises of 200% and 0.25%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?